Inova's disease-specific and advanced lung programs provide highly specialized evaluation and treatment for individuals living with serious to life-threatening lung conditions. Our lung specialists continually seek out and implement the latest treatment techniques, offering patients advancements that may delay or forestall the need for a lung transplant, or provide treatment options for those not eligible for transplantation. We partner with the National Institutes of Health (NIH) on state-of-the-art research studies to develop more effective treatments for advanced lung conditions, and offer unparalleled care that is nationally and internationally recognized.
Our Accreditations
| Alpha 1-Antitrypsin | Alpha-1 Foundation Designated Clinical Resource Center (CRC) |
| Cystic Fibrosis | Cystic Fibrosis Foundation (CFF) Accredited Care Center |
| Lung Transplant | Centers For Medicare & Medicaid Services (CMS) Accredited Lung Transplant Center |
| Pulmonary Fibrosis | Pulmonary Fibrosis Foundation (PFF) Accredited Care Center |
| Pulmonary Hypertension | Pulmonary Hypertension Association Accredited Care Center |
| Sarcoidosis | World Association For Sarcoidosis and Other Granulomatous Diseases (WASOG) Accredited Clinic |